Teriparatide
- Generic Name
- Teriparatide
- Brand Names
- Forsteo, Forteo, Movymia, Kauliv, Sondelbay, Teriparatide Sun, Terrosa, Livogiva
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 52232-67-4
- Unique Ingredient Identifier
- 10T9CSU89I
- Background
Teriparatide is a recombinant parathyroid hormone (PTH) analog and a potent osteoanabolic agent. It is made up of the first amino(N)-terminal 34 amino acids of the human PTH. First approved in the United States in November 2002 and in Europe in April 2003, teriparatide makes the first approved drug in a new category of osteoporosis therapy called anabolic th...
- Indication
Teriparatide is indicated:
- Associated Conditions
- Osteoporosis, Osteoporosis caused by Glucocorticoid Treatment, Primary Osteoporosis
- Associated Therapies
- -
Replication of the VERO Osteoporosis Trial in Healthcare Claims Data
- First Posted Date
- 2021-05-10
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 12757
- Registration Number
- NCT04879420
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).
- Conditions
- Interventions
- First Posted Date
- 2021-02-11
- Last Posted Date
- 2022-11-10
- Lead Sponsor
- Saint Petersburg State University, Russia
- Target Recruit Count
- 20
- Registration Number
- NCT04750460
- Locations
- 🇷🇺
Saint-Petersburg State University Hospital, Saint Petersburg, Russian Federation
Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and Aging
- Conditions
- Interventions
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2022-05-18
- Lead Sponsor
- University of Milano Bicocca
- Target Recruit Count
- 123
- Registration Number
- NCT04669782
- Locations
- 🇮🇹
Istituto Ortopedico Galeazzi IRCCS, Milano, Italy
Fracture Recovery for Returning to Duty (Teriparatide STRONG)
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2023-02-13
- Lead Sponsor
- University of South Carolina
- Target Recruit Count
- 183
- Registration Number
- NCT04589819
- Locations
- 🇺🇸
Fort Jackson, Columbia, South Carolina, United States
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
- Conditions
- Interventions
- First Posted Date
- 2020-08-21
- Last Posted Date
- 2024-04-23
- Lead Sponsor
- Ditte Hansen
- Target Recruit Count
- 48
- Registration Number
- NCT04522622
- Locations
- 🇩🇰
Aalborg University Hospital, Aalborg, Denmark
🇩🇰Steno Diabetes Center Copenhagen, Gentofte, Denmark
🇩🇰Herlev and Gentofte Hospital, Herlev Hospital, Herlev, Denmark
Circulating Myokine Levels and Bone Metabolism
- First Posted Date
- 2019-12-20
- Last Posted Date
- 2021-01-12
- Lead Sponsor
- 424 General Military Hospital
- Target Recruit Count
- 220
- Registration Number
- NCT04206618
- Locations
- 🇬🇷
424 General Military Hospital, Thessaloniki, Northern Greece, Greece
Study of Teriparatide in Stress Fracture Healing
- First Posted Date
- 2019-12-12
- Last Posted Date
- 2020-11-04
- Lead Sponsor
- University of East Anglia
- Target Recruit Count
- 136
- Registration Number
- NCT04196855
- Locations
- 🇬🇧
Darlington Memorial Hospital, Darlington, County Durham, United Kingdom
Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration
- First Posted Date
- 2019-07-19
- Last Posted Date
- 2023-08-02
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 37
- Registration Number
- NCT04026256
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery
- Conditions
- Interventions
- First Posted Date
- 2018-12-10
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 192
- Registration Number
- NCT03770338
- Locations
- 🇭🇰
Jason Pui Yin Cheung, Hong Kong, Please select an option below, Hong Kong
🇭🇰Duchess of Kent Children's Hospital, Hong Kong, Hong Kong
🇭🇰Queen Mary Hospital, Hong Kong, Hong Kong
Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP
- Conditions
- Interventions
- First Posted Date
- 2018-10-02
- Last Posted Date
- 2018-10-02
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 90
- Registration Number
- NCT03692143
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.